2 insiders bought €316k of shares over the last 90 days, the latest by Saurabh Goyal, filed 01 Oct 2026.
This page follows insider dealings at Nureca as filed with SEBI (PIT + SAST), a company from the Health Care sector. The last twelve months, up to 24 October 2026, brought 31 filings signed by 5 insiders.
Every open-market trade in the period is a purchase: 25 purchases worth €316k, from 3 insiders, and not a single sale. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 3 major shareholders. Saurabh Goyal filed the largest purchase, €62k, on 25 September 2026, which represents 0.21% of the company's market value.
With 31 filings in twelve months, the company is more active than the median of 4 filings across the 1,891 companies we follow on the same exchange. The full history, which starts in 2023, counts 35 purchases against no sales.
In all, 16 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 1 October 2026, 23 days ago. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. That lag is the time during which only the insider knows about the trade.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 47 declarations
Nureca is a company listed on the XBOM, specializing in the provision of health and wellness products. It focuses on innovation and quality to enhance consumers' lives.
Purchases our model currently ranks for the recommendations list.
All recommendations